APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ivosidenib

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Ivosidenib Market Analysis and Forecast 2026-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchIvosidenib Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Ivosidenib Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Ivosidenib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ivosidenib Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Ivosidenib Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Ivosidenib market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Ivosidenib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Ivosidenib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Ivosidenib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Ivosidenib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Ivosidenib include Servier Pharmaceuticals. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Ivosidenib, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Ivosidenib, also provides the sales of main regions and countries. Of the upcoming market potential for Ivosidenib, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ivosidenib sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ivosidenib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Ivosidenib sales, projected growth trends, production technology, application and end-user industry.

Ivosidenib Segment by Company

Servier Pharmaceuticals

Ivosidenib Segment by Type

60 Tablets

30 Tablets

Ivosidenib Segment by Application

Hospital

Pharmacy

Ivosidenib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ivosidenib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ivosidenib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ivosidenib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Ivosidenib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Ivosidenib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ivosidenib sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ivosidenib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 60 Tablets Major Manufacturers Table 3. 30 Tablets Major Manufacturers Table 4. Global Ivosidenib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Pharmacy Major Manufacturers Table 7. Ivosidenib Industry Trends Table 8. Ivosidenib Industry Drivers Table 9. Ivosidenib Industry Opportunities and Challenges Table 10. Ivosidenib Industry Restraints Table 11. Global Ivosidenib Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Ivosidenib Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Ivosidenib Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Ivosidenib Revenue Market Share by Region (2021-2026) Table 15. Global Ivosidenib Revenue Market Share by Region (2027-2032) Table 16. Global Ivosidenib Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (units) Table 17. Global Ivosidenib Sales by Region (2021-2026) & (units) Table 18. Global Ivosidenib Sales by Region (2027-2032) & (units) Table 19. Global Ivosidenib Sales Market Share by Region (2021-2026) Table 20. Global Ivosidenib Sales Market Share by Region (2027-2032) Table 21. Global Ivosidenib Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Ivosidenib Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Ivosidenib Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Ivosidenib Sales Market Share by Manufacturers (2021-2026) Table 25. Global Ivosidenib Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Ivosidenib Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Ivosidenib Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Ivosidenib Manufacturers, Product Type & Application Table 29. Global Ivosidenib Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Ivosidenib by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Ivosidenib Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Ivosidenib Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Ivosidenib Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Ivosidenib Revenue Market Share by Type (2021-2026) Table 36. Global Ivosidenib Revenue Market Share by Type (2027-2032) Table 37. Global Ivosidenib Sales by Type 2021 VS 2025 VS 2032 (units) Table 38. Global Ivosidenib Sales by Type (2021-2026) & (units) Table 39. Global Ivosidenib Sales by Type (2027-2032) & (units) Table 40. Global Ivosidenib Sales Market Share by Type (2021-2026) Table 41. Global Ivosidenib Sales Market Share by Type (2027-2032) Table 42. Global Ivosidenib Price by Type (2021-2026) & (US$/unit) Table 43. Global Ivosidenib Price by Type (2027-2032) & (US$/unit) Table 44. Global Ivosidenib Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Ivosidenib Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Ivosidenib Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Ivosidenib Revenue Market Share by Application (2021-2026) Table 48. Global Ivosidenib Revenue Market Share by Application (2027-2032) Table 49. Global Ivosidenib Sales by Application 2021 VS 2025 VS 2032 (units) Table 50. Global Ivosidenib Sales by Application (2021-2026) & (units) Table 51. Global Ivosidenib Sales by Application (2027-2032) & (units) Table 52. Global Ivosidenib Sales Market Share by Application (2021-2026) Table 53. Global Ivosidenib Sales Market Share by Application (2027-2032) Table 54. Global Ivosidenib Price by Application (2021-2026) & (US$/unit) Table 55. Global Ivosidenib Price by Application (2027-2032) & (US$/unit) Table 56. Servier Pharmaceuticals Company Information Table 57. Servier Pharmaceuticals Business Overview Table 58. Servier Pharmaceuticals Ivosidenib Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. Servier Pharmaceuticals Ivosidenib Product Portfolio Table 60. Servier Pharmaceuticals Recent Development Table 61. North America Ivosidenib Revenue by Type (2021-2026) & (US$ Million) Table 62. North America Ivosidenib Revenue by Type (2027-2032) & (US$ Million) Table 63. North America Ivosidenib Sales by Type (2021-2026) & (units) Table 64. North America Ivosidenib Sales by Type (2027-2032) & (units) Table 65. North America Ivosidenib Sales Price by Type (2021-2026) & (US$/unit) Table 66. North America Ivosidenib Sales Price by Type (2027-2032) & (US$/unit) Table 67. North America Ivosidenib Revenue by Application (2021-2026) & (US$ Million) Table 68. North America Ivosidenib Revenue by Application (2027-2032) & (US$ Million) Table 69. North America Ivosidenib Sales by Application (2021-2026) & (units) Table 70. North America Ivosidenib Sales by Application (2027-2032) & (units) Table 71. North America Ivosidenib Sales Price by Application (2021-2026) & (US$/unit) Table 72. North America Ivosidenib Sales Price by Application (2027-2032) & (US$/unit) Table 73. North America Ivosidenib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 74. North America Ivosidenib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 75. North America Ivosidenib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 76. North America Ivosidenib Sales by Country (2021 VS 2025 VS 2032) & (units) Table 77. North America Ivosidenib Sales by Country (2021-2026) & (units) Table 78. North America Ivosidenib Sales by Country (2027-2032) & (units) Table 79. North America Ivosidenib Sales Price by Country (2021-2026) & (US$/unit) Table 80. North America Ivosidenib Sales Price by Country (2027-2032) & (US$/unit) Table 81. United States Ivosidenib Revenue (2021-2032) & (US$ Million) Table 82. Canada Ivosidenib Revenue (2021-2032) & (US$ Million) Table 83. Mexico Ivosidenib Revenue (2021-2032) & (US$ Million) Table 84. Europe Ivosidenib Revenue by Type (2021-2026) & (US$ Million) Table 85. Europe Ivosidenib Revenue by Type (2027-2032) & (US$ Million) Table 86. Europe Ivosidenib Sales by Type (2021-2026) & (units) Table 87. Europe Ivosidenib Sales by Type (2027-2032) & (units) Table 88. Europe Ivosidenib Sales Price by Type (2021-2026) & (US$/unit) Table 89. Europe Ivosidenib Sales Price by Type (2027-2032) & (US$/unit) Table 90. Europe Ivosidenib Revenue by Application (2021-2026) & (US$ Million) Table 91. Europe Ivosidenib Revenue by Application (2027-2032) & (US$ Million) Table 92. Europe Ivosidenib Sales by Application (2021-2026) & (units) Table 93. Europe Ivosidenib Sales by Application (2027-2032) & (units) Table 94. Europe Ivosidenib Sales Price by Application (2021-2026) & (US$/unit) Table 95. Europe Ivosidenib Sales Price by Application (2027-2032) & (US$/unit) Table 96. Europe Ivosidenib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Ivosidenib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 98. Europe Ivosidenib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 99. Europe Ivosidenib Sales by Country (2021 VS 2025 VS 2032) & (units) Table 100. Europe Ivosidenib Sales by Country (2021-2026) & (units) Table 101. Europe Ivosidenib Sales by Country (2027-2032) & (units) Table 102. Europe Ivosidenib Sales Price by Country (2021-2026) & (US$/unit) Table 103. Europe Ivosidenib Sales Price by Country (2027-2032) & (US$/unit) Table 104. Germany Ivosidenib Revenue (2021-2032) & (US$ Million) Table 105. France Ivosidenib Revenue (2021-2032) & (US$ Million) Table 106. U.K. Ivosidenib Revenue (2021-2032) & (US$ Million) Table 107. Italy Ivosidenib Revenue (2021-2032) & (US$ Million) Table 108. Russia Ivosidenib Revenue (2021-2032) & (US$ Million) Table 109. Spain Ivosidenib Revenue (2021-2032) & (US$ Million) Table 110. Netherlands Ivosidenib Revenue (2021-2032) & (US$ Million) Table 111. Switzerland Ivosidenib Revenue (2021-2032) & (US$ Million) Table 112. Sweden Ivosidenib Revenue (2021-2032) & (US$ Million) Table 113. Poland Ivosidenib Revenue (2021-2032) & (US$ Million) Table 114. China Ivosidenib Revenue by Type (2021-2026) & (US$ Million) Table 115. China Ivosidenib Revenue by Type (2027-2032) & (US$ Million) Table 116. China Ivosidenib Sales by Type (2021-2026) & (units) Table 117. China Ivosidenib Sales by Type (2027-2032) & (units) Table 118. China Ivosidenib Sales Price by Type (2021-2026) & (US$/unit) Table 119. China Ivosidenib Sales Price by Type (2027-2032) & (US$/unit) Table 120. China Ivosidenib Revenue by Application (2021-2026) & (US$ Million) Table 121. China Ivosidenib Revenue by Application (2027-2032) & (US$ Million) Table 122. China Ivosidenib Sales by Application (2021-2026) & (units) Table 123. China Ivosidenib Sales by Application (2027-2032) & (units) Table 124. China Ivosidenib Sales Price by Application (2021-2026) & (US$/unit) Table 125. China Ivosidenib Sales Price by Application (2027-2032) & (US$/unit) Table 126. Asia Ivosidenib Revenue by Type (2021-2026) & (US$ Million) Table 127. Asia Ivosidenib Revenue by Type (2027-2032) & (US$ Million) Table 128. Asia Ivosidenib Sales by Type (2021-2026) & (units) Table 129. Asia Ivosidenib Sales by Type (2027-2032) & (units) Table 130. Asia Ivosidenib Sales Price by Type (2021-2026) & (US$/unit) Table 131. Asia Ivosidenib Sales Price by Type (2027-2032) & (US$/unit) Table 132. Asia Ivosidenib Revenue by Application (2021-2026) & (US$ Million) Table 133. Asia Ivosidenib Revenue by Application (2027-2032) & (US$ Million) Table 134. Asia Ivosidenib Sales by Application (2021-2026) & (units) Table 135. Asia Ivosidenib Sales by Application (2027-2032) & (units) Table 136. Asia Ivosidenib Sales Price by Application (2021-2026) & (US$/unit) Table 137. Asia Ivosidenib Sales Price by Application (2027-2032) & (US$/unit) Table 138. Asia Ivosidenib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Asia Ivosidenib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. Asia Ivosidenib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. Asia Ivosidenib Sales by Country (2021 VS 2025 VS 2032) & (units) Table 142. Asia Ivosidenib Sales by Country (2021-2026) & (units) Table 143. Asia Ivosidenib Sales by Country (2027-2032) & (units) Table 144. Asia Ivosidenib Sales Price by Country (2021-2026) & (US$/unit) Table 145. Asia Ivosidenib Sales Price by Country (2027-2032) & (US$/unit) Table 146. Japan Ivosidenib Revenue (2021-2032) & (US$ Million) Table 147. South Korea Ivosidenib Revenue (2021-2032) & (US$ Million) Table 148. India Ivosidenib Revenue (2021-2032) & (US$ Million) Table 149. Australia Ivosidenib Revenue (2021-2032) & (US$ Million) Table 150. Taiwan Ivosidenib Revenue (2021-2032) & (US$ Million) Table 151. Southeast Asia Ivosidenib Revenue (2021-2032) & (US$ Million) Table 152. SAMEA Ivosidenib Revenue by Type (2021-2026) & (US$ Million) Table 153. SAMEA Ivosidenib Revenue by Type (2027-2032) & (US$ Million) Table 154. SAMEA Ivosidenib Sales by Type (2021-2026) & (units) Table 155. SAMEA Ivosidenib Sales by Type (2027-2032) & (units) Table 156. SAMEA Ivosidenib Sales Price by Type (2021-2026) & (US$/unit) Table 157. SAMEA Ivosidenib Sales Price by Type (2027-2032) & (US$/unit) Table 158. SAMEA Ivosidenib Revenue by Application (2021-2026) & (US$ Million) Table 159. SAMEA Ivosidenib Revenue by Application (2027-2032) & (US$ Million) Table 160. SAMEA Ivosidenib Sales by Application (2021-2026) & (units) Table 161. SAMEA Ivosidenib Sales by Application (2027-2032) & (units) Table 162. SAMEA Ivosidenib Sales Price by Application (2021-2026) & (US$/unit) Table 163. SAMEA Ivosidenib Sales Price by Application (2027-2032) & (US$/unit) Table 164. SAMEA Ivosidenib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. SAMEA Ivosidenib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. SAMEA Ivosidenib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. SAMEA Ivosidenib Sales by Country (2021 VS 2025 VS 2032) & (units) Table 168. SAMEA Ivosidenib Sales by Country (2021-2026) & (units) Table 169. SAMEA Ivosidenib Sales by Country (2027-2032) & (units) Table 170. SAMEA Ivosidenib Sales Price by Country (2021-2026) & (US$/unit) Table 171. SAMEA Ivosidenib Sales Price by Country (2027-2032) & (US$/unit) Table 172. Brazil Ivosidenib Revenue (2021-2032) & (US$ Million) Table 173. Argentina Ivosidenib Revenue (2021-2032) & (US$ Million) Table 174. Chile Ivosidenib Revenue (2021-2032) & (US$ Million) Table 175. Colombia Ivosidenib Revenue (2021-2032) & (US$ Million) Table 176. Peru Ivosidenib Revenue (2021-2032) & (US$ Million) Table 177. Saudi Arabia Ivosidenib Revenue (2021-2032) & (US$ Million) Table 178. Israel Ivosidenib Revenue (2021-2032) & (US$ Million) Table 179. UAE Ivosidenib Revenue (2021-2032) & (US$ Million) Table 180. Turkey Ivosidenib Revenue (2021-2032) & (US$ Million) Table 181. Iran Ivosidenib Revenue (2021-2032) & (US$ Million) Table 182. Egypt Ivosidenib Revenue (2021-2032) & (US$ Million) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Ivosidenib Distributors List Table 186. Ivosidenib Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Ivosidenib Image Figure 2. Global Ivosidenib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ivosidenib Market Size Share 2021 VS 2025 VS 2032 Figure 4. 60 Tablets Image Figure 5. 30 Tablets Image Figure 6. Global Ivosidenib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Ivosidenib Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Pharmacy Image Figure 10. Global Ivosidenib Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Ivosidenib Revenue (2021-2032) & (US$ Million) Figure 12. Global Ivosidenib Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Ivosidenib Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Ivosidenib Revenue Market Share by Region (2021-2032) Figure 15. Global Ivosidenib Sales (2021-2032) & (units) Figure 16. Global Ivosidenib Sales by Region: 2021 VS 2025 VS 2032 (units) Figure 17. Global Ivosidenib Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Ivosidenib Sales YoY (2021-2032) & (units) Figure 19. Europe Ivosidenib Sales YoY (2021-2032) & (units) Figure 20. China Ivosidenib Sales YoY (2021-2032) & (units) Figure 21. Asia (Excluding China) Ivosidenib Sales YoY (2021-2032) & (units) Figure 22. South America, Middle East and Africa Ivosidenib Sales YoY (2021-2032) & (units) Figure 23. Global Ivosidenib Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Ivosidenib Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Ivosidenib Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Ivosidenib Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Ivosidenib Revenue Market Share by Type (2021-2032) Figure 29. Global Ivosidenib Sales by Type (2021 VS 2025 VS 2032) & (units) Figure 30. Global Ivosidenib Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Ivosidenib Sales Market Share by Type (2021-2032) Figure 32. Global Ivosidenib Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Ivosidenib Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Ivosidenib Revenue Market Share by Application (2021-2032) Figure 35. Global Ivosidenib Sales by Application (2021 VS 2025 VS 2032) & (units) Figure 36. Global Ivosidenib Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Ivosidenib Sales Market Share by Application (2021-2032) Figure 38. North America Ivosidenib Revenue Share by Type (2021-2032) Figure 39. North America Ivosidenib Sales Share by Type (2021-2032) Figure 40. North America Ivosidenib Revenue Share by Application (2021-2032) Figure 41. North America Ivosidenib Sales Share by Application (2021-2032) Figure 42. North America Ivosidenib Revenue Share by Country (2021-2032) Figure 43. North America Ivosidenib Sales Share by Country (2021-2032) Figure 44. Europe Ivosidenib Revenue Share by Type (2021-2032) Figure 45. Europe Ivosidenib Sales Share by Type (2021-2032) Figure 46. Europe Ivosidenib Revenue Share by Application (2021-2032) Figure 47. Europe Ivosidenib Sales Share by Application (2021-2032) Figure 48. Europe Ivosidenib Revenue Share by Country (2021-2032) Figure 49. Europe Ivosidenib Sales Share by Country (2021-2032) Figure 50. China Ivosidenib Revenue Share by Type (2021-2032) Figure 51. China Ivosidenib Sales Share by Type (2021-2032) Figure 52. China Ivosidenib Revenue Share by Application (2021-2032) Figure 53. China Ivosidenib Sales Share by Application (2021-2032) Figure 54. Asia Ivosidenib Revenue Share by Type (2021-2032) Figure 55. Asia Ivosidenib Sales Share by Type (2021-2032) Figure 56. Asia Ivosidenib Revenue Share by Application (2021-2032) Figure 57. Asia Ivosidenib Sales Share by Application (2021-2032) Figure 58. Asia Ivosidenib Revenue Share by Country (2021-2032) Figure 59. Asia Ivosidenib Sales Share by Country (2021-2032) Figure 60. SAMEA Ivosidenib Revenue Share by Type (2021-2032) Figure 61. SAMEA Ivosidenib Sales Share by Type (2021-2032) Figure 62. SAMEA Ivosidenib Revenue Share by Application (2021-2032) Figure 63. SAMEA Ivosidenib Sales Share by Application (2021-2032) Figure 64. SAMEA Ivosidenib Revenue Share by Country (2021-2032) Figure 65. SAMEA Ivosidenib Sales Share by Country (2021-2032) Figure 66. Ivosidenib Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Ivosidenib Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 60 Tablets
  • 30 Tablets
Applications
  • Hospital
  • Pharmacy
Companies covered
  • Servier Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Ivosidenib Market by Type
  3. 1.2.1 Global Ivosidenib Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 60 Tablets
  5. 1.2.3 30 Tablets
  6. 1.3 Ivosidenib Market by Application
  7. 1.3.1 Global Ivosidenib Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Pharmacy
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Ivosidenib Market Dynamics
  1. 2.1 Ivosidenib Industry Trends
  2. 2.2 Ivosidenib Industry Drivers
  3. 2.3 Ivosidenib Industry Opportunities and Challenges
  4. 2.4 Ivosidenib Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Ivosidenib Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Ivosidenib Revenue by Region
  3. 3.2.1 Global Ivosidenib Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Ivosidenib Revenue by Region (2021-2026)
  5. 3.2.3 Global Ivosidenib Revenue by Region (2027-2032)
  6. 3.2.4 Global Ivosidenib Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Ivosidenib Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Ivosidenib Sales by Region
  9. 3.4.1 Global Ivosidenib Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Ivosidenib Sales by Region (2021-2026)
  11. 3.4.3 Global Ivosidenib Sales by Region (2027-2032)
  12. 3.4.4 Global Ivosidenib Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Ivosidenib Revenue by Manufacturers
  2. 4.1.1 Global Ivosidenib Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Ivosidenib Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Ivosidenib Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Ivosidenib Sales by Manufacturers
  6. 4.2.1 Global Ivosidenib Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Ivosidenib Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Ivosidenib Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Ivosidenib Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Ivosidenib Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Ivosidenib Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Ivosidenib Manufacturers, Product Type & Application
  13. 4.7 Global Ivosidenib Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Ivosidenib Market CR5 and HHI
  16. 4.8.2 2025 Ivosidenib Tier 1, Tier 2, and Tier 3
5 Ivosidenib Market by Type
  1. 5.1 Global Ivosidenib Revenue by Type
  2. 5.1.1 Global Ivosidenib Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Ivosidenib Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Ivosidenib Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Ivosidenib Sales by Type
  6. 5.2.1 Global Ivosidenib Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ivosidenib Sales by Type (2021-2032) & (units)
  8. 5.2.3 Global Ivosidenib Sales Market Share by Type (2021-2032)
  9. 5.3 Global Ivosidenib Price by Type
6 Ivosidenib Market by Application
  1. 6.1 Global Ivosidenib Revenue by Application
  2. 6.1.1 Global Ivosidenib Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Ivosidenib Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Ivosidenib Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Ivosidenib Sales by Application
  6. 6.2.1 Global Ivosidenib Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Ivosidenib Sales by Application (2021-2032) & (units)
  8. 6.2.3 Global Ivosidenib Sales Market Share by Application (2021-2032)
  9. 6.3 Global Ivosidenib Price by Application
7 Company Profiles
  1. 7.1 Servier Pharmaceuticals
  2. 7.1.1 Servier Pharmaceuticals Company Information
  3. 7.1.2 Servier Pharmaceuticals Business Overview
  4. 7.1.3 Servier Pharmaceuticals Ivosidenib Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Servier Pharmaceuticals Ivosidenib Product Portfolio
  6. 7.1.5 Servier Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Ivosidenib Market Size by Type
  2. 8.1.1 North America Ivosidenib Revenue by Type (2021-2032)
  3. 8.1.2 North America Ivosidenib Sales by Type (2021-2032)
  4. 8.1.3 North America Ivosidenib Price by Type (2021-2032)
  5. 8.2 North America Ivosidenib Market Size by Application
  6. 8.2.1 North America Ivosidenib Revenue by Application (2021-2032)
  7. 8.2.2 North America Ivosidenib Sales by Application (2021-2032)
  8. 8.2.3 North America Ivosidenib Price by Application (2021-2032)
  9. 8.3 North America Ivosidenib Market Size by Country
  10. 8.3.1 North America Ivosidenib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Ivosidenib Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Ivosidenib Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Ivosidenib Market Size by Type
  2. 9.1.1 Europe Ivosidenib Revenue by Type (2021-2032)
  3. 9.1.2 Europe Ivosidenib Sales by Type (2021-2032)
  4. 9.1.3 Europe Ivosidenib Price by Type (2021-2032)
  5. 9.2 Europe Ivosidenib Market Size by Application
  6. 9.2.1 Europe Ivosidenib Revenue by Application (2021-2032)
  7. 9.2.2 Europe Ivosidenib Sales by Application (2021-2032)
  8. 9.2.3 Europe Ivosidenib Price by Application (2021-2032)
  9. 9.3 Europe Ivosidenib Market Size by Country
  10. 9.3.1 Europe Ivosidenib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Ivosidenib Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Ivosidenib Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Ivosidenib Market Size by Type
  2. 10.1.1 China Ivosidenib Revenue by Type (2021-2032)
  3. 10.1.2 China Ivosidenib Sales by Type (2021-2032)
  4. 10.1.3 China Ivosidenib Price by Type (2021-2032)
  5. 10.2 China Ivosidenib Market Size by Application
  6. 10.2.1 China Ivosidenib Revenue by Application (2021-2032)
  7. 10.2.2 China Ivosidenib Sales by Application (2021-2032)
  8. 10.2.3 China Ivosidenib Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Ivosidenib Market Size by Type
  2. 11.1.1 Asia Ivosidenib Revenue by Type (2021-2032)
  3. 11.1.2 Asia Ivosidenib Sales by Type (2021-2032)
  4. 11.1.3 Asia Ivosidenib Price by Type (2021-2032)
  5. 11.2 Asia Ivosidenib Market Size by Application
  6. 11.2.1 Asia Ivosidenib Revenue by Application (2021-2032)
  7. 11.2.2 Asia Ivosidenib Sales by Application (2021-2032)
  8. 11.2.3 Asia Ivosidenib Price by Application (2021-2032)
  9. 11.3 Asia Ivosidenib Market Size by Country
  10. 11.3.1 Asia Ivosidenib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Ivosidenib Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Ivosidenib Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Ivosidenib Market Size by Type
  2. 12.1.1 SAMEA Ivosidenib Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Ivosidenib Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Ivosidenib Price by Type (2021-2032)
  5. 12.2 SAMEA Ivosidenib Market Size by Application
  6. 12.2.1 SAMEA Ivosidenib Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Ivosidenib Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Ivosidenib Price by Application (2021-2032)
  9. 12.3 SAMEA Ivosidenib Market Size by Country
  10. 12.3.1 SAMEA Ivosidenib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Ivosidenib Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Ivosidenib Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Ivosidenib Value Chain Analysis
  2. 13.1.1 Ivosidenib Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Ivosidenib Production Mode & Process
  6. 13.2 Ivosidenib Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Ivosidenib Distributors
  9. 13.2.3 Ivosidenib Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst